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Vestigial-like 2 contributes 
to normal muscle fiber type 
distribution in mice
Masahiko Honda1, Kyoko Hidaka1,2, So-ichiro Fukada  3, Ryo Sugawa1, Manabu Shirai1, 
Masahito Ikawa  4 & Takayuki Morisaki1,5
Skeletal muscle is composed of heterogeneous populations of myofibers that are classified as slow- 
and fast-twitch fibers. The muscle fiber-type is regulated in a coordinated fashion by multiple genes, 
including transcriptional factors and microRNAs (miRNAs). However, players involved in this regulation 
are not fully elucidated. One of the members of the Vestigial-like factors, Vgll2, is thought to play a 
pivotal role in TEA domain (TEAD) transcription factor-mediated muscle-specific gene expression 
because of its restricted expression in skeletal muscles of adult mice. Here, we generated Vgll2 null mice 
and investigated Vgll2 function in adult skeletal muscles. These mice presented an increased number of 
fast-twitch type IIb fibers and exhibited a down-regulation of slow type I myosin heavy chain (MyHC) 
gene, Myh7, which resulted in exercise intolerance. In accordance with the decrease in Myh7, down-
regulation of miR-208b, encoded within Myh7 gene and up-regulation of targets of miR-208b, Sox6, 
Sp3, and Purβ, were observed in Vgll2 deficient mice. Moreover, we detected the physical interaction 
between Vgll2 and TEAD1/4 in neonatal skeletal muscles. These results suggest that Vgll2 may be both 
directly and indirectly involved in the programing of slow muscle fibers through the formation of the 
Vgll2-TEAD complex.
Adult mammalian skeletal muscles are made up of heterogeneous populations of myofibers that display distinct 
contractile and metabolic properties1–3. Muscle fiber types are classified as slow- or fast-twitch fibers based on 
their contractility. Slow-twitch (Type I) fibers are mitochondrial-rich, exhibit oxidative metabolism and fatigue 
resistance, and express slow isoforms of sarcomeric proteins, including MyHCI, encoded by Myh7. In contrast, 
fast-twitch (Type II) fibers express fast isoforms of sarcomeric proteins, fatigue rapidly, and are subclassified as 
type IIa, IIx, and IIb based on the expression of Myh2 (MyHCIIa), Myh1 (MyHCIIx), and Myh4 (MyHCIIb), 
respectively4. Type IIa fibers are mitochondrial-rich and exhibit oxidative metabolism. Type IIb fibers have 
low density of mitochondria and rely on glycolytic metabolism. Type IIx fibers are intermediate. Therefore, the 
amount and type of MyHC in each skeletal muscle are major indicators of the function of each muscle, including 
endurance, fatigability, and metabolism.
The process of muscle fiber-type specification is controlled by multiple steps. After embryonic and fetal myo-
genesis, the pattern of MyHC expression at birth is similar in all skeletal muscles in mice5, 6, whereas the pattern 
of MyHC isoform expression is modified according to physical and functional demands during postnatal life. 
The muscles then attain a mature phenotype that is functionally distinct. Previous studies identified many tran-
scriptional pathways underlying the regulation of basal-muscle fiber type-specific gene expression, exogenous 
stimulus-induced fiber type modulation, and myofiber metabolism7–17. In addition to protein-encoding genes, 
miRNAs have emerged as new players in functional modulation of myofibers by participating in orchestrated 
gene regulation processes18–21.
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In Drosophila, the nuclear protein, Vestigial, is the essential cofactor of Scalloped, a homolog of TEA domain/
transcription enhancer factor (TEAD/TEF) family of transcription factors and plays a pivotal role in the devel-
opment and patterning of the wing22, 23. Vestigial is also a necessary cofactor of Scalloped for muscle differentia-
tion24. Mammalian vestigial-like 1–4 (Vgll1–4) proteins possess the TEF-1 interaction domain called the tondu 
(TDU) motif and contribute to the tissue-specific functions of the TEAD factors25–27. Of these, Vgll2 (also known 
as VITO-1) is expressed in the somitic myotome and pharyngeal pouch during mouse development, while it 
is selectively expressed in skeletal muscle in the adult25, 26. Previous studies showed that Vgll2 overexpression 
augments MyoD-mediated myogenic conversion of 10T1/2 cells26, 28. Conversely, knockdown studies using anti-
sense morpholino showed that inhibition of Vgll2 expression attenuates MyHC expression in C2C12 myoblasts 
and avian limb muscles29. In addition, skeletal muscle specific overexpression of TEAD1 induces fast-to-slow 
fiber-type transition in adult mice30. Thus, previous studies have implicated a role for Vgll2 in in vitro muscle 
differentiation, but its in vivo function is poorly understood.
In this study, we found that Vgll2-deficient mice exhibited a faster muscle contractile phenotype under basal 
conditions and significant expression changes of Myh7/miR-208b and its downstream targets of transcriptional 
repressor proteins for slow-twitch fiber in neonatal skeletal muscles. We further provide evidences that Vgll2 
forms a protein complex with TEAD1/4. Our study reveals that Vgll2 has potent activity in normal skeletal mus-
cle fiber distribution in both direct and indirect contribution in vivo.
Results
Preferential Expression of Vgll2 in Slow Muscle. Previous studies suggested a role for Vgll2 in the 
MyHC expression during myogenic differentiation of C2C12 myoblasts29, but the potential function of Vgll2 
in adult muscle is unknown. To elucidate the function of Vgll2 in vivo, we first examined whether Vgll2 mRNA 
displays preferential expression patterns between individual skeletal muscles that differ in fiber type composition 
in 12-week-old mice. The expression level of Vgll2 mRNA was significantly higher in the Type I and IIa fiber-en-
riched slow soleus muscle than in the Type IIb fiber-enriched fast gastrocnemius and extensor digitorum longus 
(EDL) muscles (Fig. 1a). Hence, we speculated that Vgll2 may play a role in the control of the specification of 
adult muscle fiber-type.
Generation of Vgll2-Deficient Mice. To determine the influence of Vgll2 deficiency in vivo, we generated 
Vgll2 knockout mice with targeted replacement of the Vgll2 loci by the lacZ gene in D3 ES cells (Fig. 1b). To 
construct a targeting vector, we obtained DNA fragments encoding Vgll2 from a mouse EB3 cell genomic DNA 
library31, 32. Homologously recombined ES colonies and heterozygous mice were verified by Southern blot analysis 
(Fig. 1c). After mating heterozygous mice, all genotypes, Vgll2+/+, Vgll2+/−, and Vgll2−/− were identified (52, 106, 
and 45, x2 = 0.68, chi-square test), which segregated according to the laws of Mendelian inheritance, indicating 
no marked embryonic lethality. Quantitative real-time PCR (qPCR) analysis revealed that Vgll2 transcript was 
absent in skeletal muscle from Vgll2−/− mice (Fig. 1a). Moreover, Vgll2 protein was detected only in the nuclear 
extracts prepared from the Vgll2+/+ soleus muscle by Western blotting with anti-Vgll2 antibody (see “Materials 
and Methods”), but not in Vgll2−/− (Fig. 1d). Compensatory responses in other Vgll family genes such as Vgll3 
and Vgll4, which are also expressed in skeletal muscle, were not observed in Vgll2−/− mice (Supplementary 
Fig. S1).
Vgll2 Deficiency Induces a Slow-to-Fast Transformation of Muscle Fiber-Type. Vgll2−/− mice dis-
played no overt abnormalities. The preferential accumulation of Vgll2 mRNA in the slow soleus muscle led us to 
investigate the fiber type composition in mice lacking Vgll2. To characterize the fiber type in Vgll2−/− mice, we 
measured the relative expression levels of several MyHC isoforms by qPCR in neonatal and adult skeletal mus-
cles. In Vgll2−/− gastrocnemius-plantaris-soleus (GPS) muscle at postnatal day 7 (P7), expression levels of Myh7, 
encoding slow type I myosin, were significantly reduced by 24% (Fig. 2), whereas the expression of the fast MyHC 
isoform gene, Myh4, was significantly increased (Fig. 2). These alterations in MyHC expression profiles were also 
observed in 12-week-old Vgll2−/− mice. In Vgll2−/− slow twitch soleus muscle, expression levels of Myh7 were 
significantly decreased by 47%, whereas fast myosin genes, Myh1 and Myh4 were markedly increased 2.9- and 
10.5-fold (Fig. 3a). We did not detect significant changes in the expression levels of all MyHC isoforms in Vgll2+/− 
soleus muscle (Supplementary Fig. S2). In addition, in the fast gastrocnemius and EDL muscle groups, expressing 
low levels of Vgll2 mRNA, Myh7, Myh2, and Myh1 expression levels were significantly reduced, whereas Myh4 
expression was sustained (Fig. 3a). Next, we determined the relative content of MyHC isoform type I, IIa (and/
or IIx), and IIb by gel electrophoresis and immunostaining of each skeletal muscle (Fig. 3b,c and Supplementary 
Fig. S3). In Vgll2−/− soleus muscle, a muscle normally rich in type I and IIa fibers, both type I and type IIa fibers 
were reduced, and an obvious increase in type IIb fibers was detected (Fig. 3b,c and Supplementary Fig. S3). In 
Vgll2+/+ soleus muscle, type IIb fibers were very rarely detected (Fig. 3b,c and Supplementary Fig. S3). Moreover, 
Vgll2−/− EDL myosin electrophoretogram showed that fast type IIa and IIx myosin were predominantly replaced 
by the fastest type IIb myosin (Fig. 3b), consistent with the changes in Myh2 and Myh1 expression levels (Fig. 3a). 
Thus, these observations suggest that a slow-to-fast contractile phenotype transition may occur in Vgll2-deficient 
mice.
Reduced Exercise Endurance in Vgll2 KO Mice. Changes in contractile properties of skeletal muscle 
have a considerable impact on physical activity. We therefore assessed the endurance capacity and grip strength 
of mice under involuntary conditions. Muscle endurance in Vgll2+/+ and Vgll2−/− mice were evaluated by tread-
mill running to exhaustion. After acclimatization, mice were allowed to run on the treadmill set to a 10% incline 
at increasing speed until the mice were unable to remain on the treadmill despite prodding. Vgll2−/− mice were 
able to run for a significantly shorter time than Vgll2+/+ mice did. Vgll2+/+ mice ran for an average of 21.6 min, 
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while Vgll2−/− mice ran for 14.2 min (Fig. 4a). Correspondingly, the running distance was significantly lower for 
Vgll2−/− mice compared to that ran by Vgll2+/+ mice. The distance covered by Vgll2−/− mice was 200.3 meters on 
average, whereas Vgll2+/+ mice ran 374.7 meters on average (Fig. 4b). Grip strength was not reduced in Vgll2−/− 
mice (Fig. 4c). These results indicate that, in skeletal muscles, Vgll2 contributes greatly to exercise endurance.
Direct Binding of Vgll2 to TEF/TEAD in the Skeletal Muscle. Vgll2 possesses an evolutionarily con-
served TDU motif, which binds to TEAD transcription factors. Previous studies suggested a role for TEF/TEAD 
family member, TEAD1 and TEAD4 in the regulation of slow muscle gene expression30, 33–36. Vgll2 deficient 
mice showed fiber type composition changes in skeletal muscle and reduced endurance. Our findings suggest 
that Vgll2 may be required for TEAD-mediated muscle fiber-type regulation, as one of the cofactors. To find 
Figure 1. Expression patterns of Vgll2 mRNA expression in several muscles, and generation of Vgll2-deficient 
mice. (a) Vgll2 mRNA levels were measured by qPCR in the soleus (SOL), gastrocnemius (GAS), and extensor 
digitorum longus (EDL) muscles from 12-week-old Vgll2+/+ and Vgll2−/− mice (n = 6). *P < 0.05 vs. Vgll2+/+ 
soleus muscles. Data are presented as mean ± SEM. For comparison, the expression level in Vgll2+/+ soleus was 
arbitrarily set at 1. (b) Schematic diagram showing the strategy used to generate the Vgll2 null allele. The top 
row depicts the wild-type Vgll2 allele, which consists of three exons (solid boxes). The initiation Met codon for 
Vgll2 exists in exon 1. The second row depicts the targeting construct. The third row depicts the mutated Vgll2 
allele. The lacZ expression cassette with a SV40 polyadenylation signal, which was followed by the loxP-flanked 
puromycin resistant gene expression cassette (Puro) in the reverse orientation, was fused to the initiation codon 
of Vgll2. The diphtheria toxin A expression cassette (DT-A) was included at the 5′-end of the targeting vector. 
The external probe used for Southern blot analysis lies outside the 5′-homologous arm (gray box). RI, EcoRI; RV, 
EcoRV. (c) Southern blot analysis for genotyping wild-type (Vgll2+/+), heterozygous Vgll2-deficient (Vgll2+/−), 
and homozygous Vgll2-deficient (Vgll2−/−) animals. Digestion with EcoRI of Vgll2+/+ and Vgll2−/− alleles 
gave rise to fragments of 2.2 and 4.6 kb, respectively. An uncropped original image is shown in Supplementary 
information. (d) Vgll2 protein levels were assessed by Western blotting using nuclear protein extracts obtained 
from the soleus muscle of 12-week-old Vgll2+/+ and Vgll2−/− mice. Histone H2B served as a loading control. 
Analyses were performed on four mice per genotype. Data from two mice per genotype are shown. Uncropped 
original images are shown in Supplementary information.
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the physical interaction between Vgll2 and TEAD1 in skeletal muscles, we conducted co-immunoprecipitation 
experiments using extracts from neonatal (P7) GPS muscles. As expected, endogenous TEAD1 and TEAD4 pro-
teins were efficiently co-immunoprecipitated by the anti-Vgll2 antibody only in Vgll2+/+ extracts, but not in Vgll2 
KO extracts (Fig. 5a). In addition, reciprocal co-immunoprecipitation with an anti-TEAD1 antibody precipitated 
endogenous Vgll2 only in Vgll2+/+ extracts (Fig. 5b). Similarly, co-immunoprecipitation with an anti-TEAD4 
antibody precipitated endogenous Vgll2 only in Vgll2+/+ extracts (Fig. 5c). Together, our findings raise the possi-
bility that Vgll2 plays a cooperative role in TEAD1/4-associated transcription in skeletal muscle through protein 
binding.
To examine whether Vgll2 deficiency alters the expression levels of other TEAD cofactors such as Yap and 
Taz27, 37, 38, we quantified these genes by qPCR. However, we did not detect significant changes in the expression 
levels of these genes (Supplementary Fig. S4).
Figure 2. Expression analysis of myosin heavy chain isoforms in neonatal skeletal muscle. Expression levels 
of MyHC isoforms were measured by qPCR in the gastrocnemius-plantaris-soleus (GPS) muscle complex at 
postnatal day 7 (P7) of Vgll2+/+ and Vgll2−/− mice (n = 8). Myh7 (encoding MyHCI), Myh2 (MyHCIIa), Myh1 
(MyHCIIx), Myh4 (MyHCIIb), Myh7b (slow-tonic MyHC), Myh3 (embryonic fast isoform, MyHC-emb), and 
Myh8 (perinatal fast isoform, MyHC-pn) expression levels were examined. For comparison, the expression level 
of these genes in Vgll2+/+ mice was arbitrarily set at 1. Data are presented as mean ± SEM. *P < 0.05 vs. Vgll2+/+ 
muscles.
Figure 3. Fiber type composition analysis based on the expression of myosin heavy chain isoforms in adult 
skeletal muscles. (a) Expression levels of genes encoding MyHC isoforms, Myh7 (I), Myh2 (IIa), Myh1 (IIx), 
and Myh4 (IIb) were measured by qPCR in the soleus, gastrocnemius, and EDL muscles from 12-week-old 
Vgll2+/+ and Vgll2−/− mice (n = 6). For comparison, the expression level of these genes in Vgll2+/+ mice was 
arbitrarily set at 1. Data are presented as mean ± SEM. *P < 0.05 vs. Vgll2+/+ in each muscle. (b) High resolution 
gel electrophoresis for MyHC isoform separation of protein extracts isolated from the soleus and EDL muscles 
of 12-week-old Vgll2+/+ and Vgll2−/− mice. Equal amounts (50 ng) of total protein were separated on an 8% 
acrylamide gel containing glycerol. The gel was then stained with the silver stain method. Uncropped original 
images are shown in Supplementary information. (c) Representative images of immunostained soleus muscles 
isolated from 12-week-old Vgll2+/+ and Vgll2−/− mice (n = 3). Scale bar: 200 μm.
www.nature.com/scientificreports/
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Downregulation of miR-208b Expression in Vgll2 Deficient Skeletal Muscle and Increase in its 
Target Proteins. We next sought to investigate the molecular mechanisms underlying slow-to-fast fiber-type 
transition in Vgll2−/− mice. Previous studies showed that two miRNAs, miR-208b and miR-499, serve as 
fiber-type modulators by inhibiting the activity of transcriptional repressors of genes encoding slow-twitch con-
tractile proteins such as Sox6, Sp3, and Purβ21, 39–42. Although these miRNAs share a comparable seed sequence 
and target the same mRNAs, they are differentially regulated: miR-208b is encoded within the Myh7 gene, and 
miR-499 is encoded within Myh7b gene43. We measured the relative expression levels of these miRNAs in neona-
tal skeletal muscles by qPCR. At P7, consistent with gene expression results of their host MyHC mRNAs (Fig. 2), 
the expression level of miR-208b was significantly reduced in Vgll2−/− GPS muscles by 39%, whereas miR-499 
expression was slightly increased (Fig. 6).
In order to further validate the reduction in miR-208b in Vgll2−/− skeletal muscles, we compared protein levels 
of its downstream targets, Sox6, Sp3, and Purβ by Western blotting analysis. In Vgll2−/− GPS muscles at P7, Sox6 
and Sp3 protein levels were markedly increased, while Purβ protein level was moderately increased (Fig. 7a). 
Collectively, our findings suggest that Vgll2 directly and indirectly participates in the specification of mature 
skeletal muscle fiber characteristics.
Discussion
In the present study, we provide the first in vivo evidence that the transcription cofactor, Vgll2, plays a role in 
muscle fiber-type distribution and physical performance. The Absence of Vgll2 results in shifts in fiber type of 
skeletal muscle toward a faster phenotype and decreases in slow isoform MyHC gene and its intronic miRNA, 
Figure 4. Analysis of muscle functions in Vgll2 null mice. (a,b) Physical endurance was measured by using a 
treadmill running test. After acclimation, mice ran on a 10% slope with a protocol using increasing speed until 
mice were exhausted. Exhaustion was defined as the inability of the mice to remain on the treadmill despite 
physical prodding. Running time (a) and speed were measured, and the distance (b) was calculated.  
(c) Skeletal muscle strength was assessed by using the grip strength test. Grip strength was measured in each 
mouse 20 times and the highest value of each experiment was used. Male mice (11–13-week-old) were used in 
all experiments (n = 8). Data are presented as mean ± SEM. *P < 0.05 vs. Vgll2+/+ mice.
www.nature.com/scientificreports/
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Figure 5. Physical interaction analysis between endogenous Vgll2 and TEAD1 in skeletal muscles at the 
neonatal stage. (a) Immunoprecipitation was conducted with the anti-Vgll2 antibody followed by Western blot 
analysis to detect TEAD1, TEAD4 and Vgll2 in GPS muscle extracts from Vgll2+/+ and Vgll2−/− mice at P7.  
(b) Immunoprecipitation was conducted with an anti-TEAD1 antibody followed by Western blot analysis to 
detect Vgll2 and TEAD1 in P7 GPS muscle extracts. (c) Immunoprecipitation was conducted with an anti-
TEAD4 antibody followed by Western blot analysis to detect Vgll2 and TEAD4 in P7 GPS muscle extracts. 
Control samples were GPS muscle lysates incubated without anti-Vgll2 or -TEAD1 antibody (no-Ab). 
Uncropped original images are shown in Supplementary information.
Figure 6. Expression analysis of miRNAs in the neonatal skeletal muscle. miR-208b and miR-499 expression 
levels in the GPS muscle from Vgll2+/+ and Vgll2−/− mice at P7 (n = 8). For comparison, the expression level of 
these miRNAs in Vgll2+/+ mice was arbitrarily set at 1. Data are presented as mean ± SEM. *P < 0.05 vs. Vgll2+/+ 
muscles.
www.nature.com/scientificreports/
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Myh7/miR-208b, and deregulation of miR-208b targets. As physical interaction between Vgll2 and TEAD1/4 were 
detected in neonatal muscles, we propose a possible mechanism involved in the programing of slow muscle fibers 
through the formations of Vgll2-TEAD1/4 complex (Fig. 7b).
Although several in vitro studies provided evidence that Vgll2 promotes skeletal muscle differentiation in cul-
tured muscle cells26, 28, its in vivo role in this capacity has not been investigated in skeletal muscle tissues. Herein, 
we show that Vgll2 is involved in the establishment and maintenance of adult skeletal muscle phenotypes. At P7, 
before the establishment of adult muscle fiber phenotype, gene expression analysis by qPCR revealed that Vgll2 
deficient skeletal muscle presented a faster MyHC profile. Furthermore, this faster MyHC profile was maintained 
in adult mice. Both transcript and protein levels of MyHCIIa in adult Vgll2−/− mice were dramatically decreased 
in slow and fast twitch muscles when compared to that in WT mice. Similarly, reduced expression of MyHCI was 
observed at both the transcript and protein levels. The changes in fast isoforms of MyHC expression were prom-
inent in the slow soleus muscle. Transcript and protein levels of MyHCIIx and IIb were dramatically increased. 
On the other hand, MyHCIIx expression was significantly decreased while that of MyHCIIb was sustained in fast 
muscle groups such as the gastrocnemius and EDL. Taken together, our experimental results show that Vgll2 may 
be required not only for the establishment, but also for the maintenance of the adult slow muscle phenotype. A 
conditional knockout approach may serve to clear Vgll2 function in skeletal muscle development and exclude the 
possibility of the loss of Vgll2 during development that might affect muscle fiber type distribution in adult mice.
Figure 7. Expression analysis of transcriptional repressor proteins in the neonatal skeletal muscles. (a) Sox6, 
Sp3, and Purβ protein levels were assessed by Western blotting in the GPS muscle from Vgll2+/+ and Vgll2−/− 
mice at P7. β-Actin was used as a loading control. Analyses were performed on four mice per genotype. Data 
from two mice per genotype are shown. Uncropped original images are shown in Supplementary information. 
(b) Schematic representation of the possible mechanism of TEAD1-mediated Vgll2 functions in muscle fiber 
type regulation.
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Muscle fiber composition is an important determinant of muscle endurance in animals, along with the capac-
ity for mitochondrial fuel oxidation and ATP synthesis44–46. Consequently, slow-to-fast fiber-type transformation 
often leads to a reduction in exercise endurance47–49. In the treadmill running experiments, the running distance 
and time were significantly decreased in Vgll2−/− mice, indicating that genetic deletion of Vgll2 impaired the 
endurance capacity of the mice. On the other hand, there was no difference in grip strength between Vgll2−/− 
and control animals, suggesting that Vgll2 activity is dispensable for the maintenance of muscle integrity. Thus, 
slow-to-fast fiber type transformation of skeletal muscle in Vgll2−/− mice has distinct effects on physical activity.
Previous reports showed that Vgll2 can activate TEAD family transcription factors by physical interaction in 
in vitro assays26. We verified that Vgll2 forms a complex with TEAD1/4 in neonatal muscle. TEAD1/4 regulates 
the expression of muscle specific genes. Overexpression of TEAD1 induces a transition toward a slow muscle 
contractile phenotype and satellite cell hyperplasia30, 50. These previous data indicate that TEAD1 are sufficient 
factors in both muscle specific gene expression and regeneration. However, they require additional factors or 
coactivators for gene expression51. It is noteworthy that TEAD1/4 expression is not restricted to specific tissues. 
Hence, skeletal muscle-specific functions are conferred by muscle-specific cofactors. In recent studies, several 
cofactors for TEAD family members have been identified, including YAP/TAZ, p160 family of nuclear receptor 
coactivators, and other Vgll members26, 27, 37, 38, 52–54. Vgll2 is exclusively expressed in skeletal muscles in adult 
animals25, 26. In addition, we now show that Vgll2 is more highly expressed in slow muscle groups. Thus, our data 
suggest the possibility that Vgll2 contribute to TEAD-dependent regulation of muscle-specific genes, especially 
in slow-twitch muscle.
Many striated muscle-specific genes contain muscle-specific cytidine-adenosine-thymidine (MCAT) elements 
in the control region55–57. MyHCI is also a well-established MCAT-element containing gene. Several previous 
studies described that the Myh7 promoter was activated by TEAD proteins through the direct binding of TEAD 
proteins on MCAT sequences58–60. Together with our results, these data suggest that MyHCI might be one of the 
direct targets of the Vgll2-TEAD1/4 complex. Interestingly, miR-208b, which works as a slow type regulator in 
a miRNA-mediated transcriptional regulatory network, was also decreased in the GPS muscles of Vgll2−/− neo-
nates in parallel with Myh7 expression. miR-208b represses negative regulators of slow-twitch muscle genes such 
as Sox6, Sp3, and Purβ21. In our study, the expression of Sox6, Sp3, and Purβ proteins was increased in Vgll2 
deficient GPS muscles. As miR-208b uses the Myh7 promoter21, the Vgll2-TEAD1 complex may also regulate 
miR-208b expression through Myh7 promoter regulation.
In our gene expression analysis, MyHCIIa was remarkably decreased in Vgll2-deficient muscles. Impairment 
of exercise tolerance in Vgll2-deficient mice could be induced by downregulation of not only MyHCI, but also 
MyHCIIa because type IIa fibers are mitochondria rich and are resistant to fatigue. Thus, MyHCIIa might be a 
target of Vgll2. Although several studies described the regulatory mechanisms of MyHCIIa expression8, 61, 62, 
MCAT and its related elements have not been identified in the MyHCIIa regulatory region. Additional studies are 
required to understand how Vgll2-associated transcription pathway participates in this regulation. The expres-
sion of Myh1, encoding MyHCIIx, is also significantly decreased in Vgll2 deficient GPS muscles at P7. Given that 
Myh1 is one of the Sox6 target genes41, it raises the possibility that the decrease in Myh1 expression is associated 
with an increase in Sox6 protein. Thus, both direct and indirect involvements of Vgll2 are proposed for muscle 
fibers regulation.
This study sheds light on the role for Vgll2 in slow-twitch myofiber gene expression in vivo. After determina-
tion by basal regulation, muscle fiber type is modified in response to external stimuli like muscle usage. Previous 
studies implicated TEAD1 in the exercise-induced fiber type remodeling30. Additional experiments are necessary 
to elucidate the participation of Vgll2 in the regulation of exercise-induced fast-to-slow fiber type transition. 
Furthermore, previous studies pointed out the possibility that Vgll2 can interact with another transcription factor, 
MEF2C26. Further analyses are warranted to fully investigate Vgll2 interaction factors and its downstream target 
genes.
In summary, this study provides the first in vivo evidence that Vgll2 participates in muscle fiber-type spec-
ification and in the maintenance of normal muscle fiber composition at the adult stage under basal conditions. 
Moreover, our findings suggested the direct and indirect involvement of the Vgll2-TEAD1 complex in the regu-
latory program for slow skeletal muscle gene expression.
Methods
Antibody Production. Peptides corresponding to residues 293 to 308 (QSLGLSVDSGKRRREC) of mouse 
Vgll2 were synthesized as an immunogen for the production of polyclonal antibodies in rabbits using a custom-
ized service (MBL, Nagoya, Japan). After verification of Vgll2 specificity by ELISA and Western blotting, the 
antiserum was affinity-purified against the peptide.
Construction of the Targeting Vector. The targeting construct (Fig. 1b) contained 1.3 kb and 7.4 kb of 
Vgll2 homologous sequences on the 5′ and 3′ regions of the lacZ expression cassette with a SV40 polyadenylation 
signal, which followed the Vgll2 initiation codon. The loxP-flanked puromycin-resistance gene expression cas-
sette (Puro) driven by a phosphoglycerate kinase promoter was inserted in the reverse orientation after the lacZ 
expression cassette. The diphtheria toxin A expression cassette (DT-A) was included at the 5′-end of the targeting 
vector for negative selection.
Generation of Vgll2-Deficient Mice. The D3 mouse embryonic stem cells63 were electroporated with the 
targeting vector and selected in medium containing puromycin. Targeted clones were identified by Southern 
blotting using the DIG High prime DNA Labeling and Detection Starter Kit II (Roche, Basel, Switzerland) with 
5′-external probes. Chimeric mice were obtained by injection of positive ES cells into blastocysts and crossed with 
wild-type C57BL/6 J mice (Japan SLC, Hamamatsu, Japan) to test for germline transmission of the disrupted Vgll2 
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allele. The genotypes of offspring were examined by Southern blotting analysis. To establish a mouse line carrying 
the disrupted Vgll2 allele, heterozygous mice were backcrossed with C57BL/6 J mice. The mouse experiments 
were approved by the Animal Care and Use Committee of the National Cerebral and Cardiovascular Center in 
Japan, and were performed in accordance with the institutional and national guidelines and regulations.
RNA Isolation, Reverse Transcription, and Quantitative Real Time PCR. Total RNA was extracted 
with miRNeasy mini Kit (QIAGEN, Hilden, Germany). For mRNA analysis, cDNA was synthesized with 
SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) using 2 μg of total RNA and random hex-
amers (Invitrogen). For miRNA analysis, cDNA was synthesized with Universal cDNA Synthesis Kit II (Exiqon, 
Vedbaek, Denmark) using 10 ng of total RNA. cDNA was amplified, using either Power SYBR Green PCR Mater 
Mix (Applied Biosystems, Foster City, CA, USA), Eagle Taq Master Mix with ROX (Roche), or ExiLENT SYBR 
Green master mix (Exiqon), with a 7900HT Fast Real Time PCR System (Applied Biosystems). The primer 
sequences used in this study were as follows: Vgll2: forward (F) 5′-CAGCAGCAAAGCACACAGAAG-3′ 
and reverse (R) 5′-TACGCGCTGTTCCAGAAGG-3′; Myh7: (F) 5′-CTACAGGCCTGGGCTTACCT-3′ 
and (R) 5′-TCTCCTTCTCAGACTTCCGC-3′; Myh2: (F) 5′-ATCCAAGTTCCGCAAGATCC-3′ and 
(R) 5′-TTCGGTCATTCCACAGCATC-3′; Myh1: (F) 5′-ATGAACAGAAGCGCAACGTG-3′ and (R) 
5′-AGGCCTTGACCTTTGATTGC-3′; Myh4: (F) 5′-AGACAGAGAGGAGCAGGAGAGTG-3′ and 
(R) 5′-CTGGTGTTCTGGGTGTGGAG-3′ ; Myh7b: (F) 5′-AGAGTGTGGAGCAGGTGGTATT-3′ 
and (R) 5′-GGTCTGATTGATTCGAGAAACC-3′; Myh3: (F) 5′-TGAACAGATTGCCGAGAACG-3′ 
and (R) 5′-GGAGAATCTTGGCTTCTTCGTG-3′; Myh8: (F) 5′-ATCGTGAGAACCAGTCCATCC-3′ 
and (R) 5′-TTTGCCAGACTCCTCCTTCTTC-3′, Vgll3: (F) 5′-CAGGGAGACATTGGGTCAGT-3′ 
and (R) 5′-TGGTCCAAAAGGAAGTTGGA-3′, Vgll4: (F) 5′-CTACCGGAGACCACCCAGT-3′ and 
(R) 5′-GCAAAGTGGTCATCCACTGA-3′ ,Yap: (F) 5′-CCCGACTCCTTCTTCAAGC-3′  and (R) 
5′-CTCGAACATGCTGTGGAGTC-3′, and Taz: (F) 5′-GAAGGTGATGAATCAGCCTCTG-3′ and (R) 
5′-GTTCTGAGTCGGGTGGTTCTG-3′. Taqman Gene Expression Assay for mouse ACTB (beta actin) endog-
enous control (4352341E) was purchased from Applied Biosystems. For miRNA analysis, the following pre-
designed primer sets were purchased from Exiqon and used: U6 (203907); hsa-miR-208b-3p (204636); and 
hsa-miR-499a-5p (205935). ACTB and U6 were used as reference genes for normalization of mRNA and miRNA 
level, respectively.
Western Blotting Analysis. For total protein extracts, muscles isolated from both legs of each mouse were 
homogenized in buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxy-
cholate, 0.1% SDS) supplemented with protease inhibitor (Complete Ultra Mini Protease inhibitor cocktail tablets 
used as instructed; Roche) and phosphatase inhibitor (PhosSTOP phosphatase inhibitor cocktail tablets used as 
instructed; Roche) using a BioMasher II homogenizer (Nippi, Tokyo, Japan). ProteoExtract Subcellular Proteome 
Extraction Kits (Merck Millipore, Darmstadt, Germany) were used according to the manufacturer’s instructions 
with some modifications to prepare nuclear extracts. Briefly, snap frozen muscles isolated from both legs of each 
mouse were homogenized directly in extraction buffer II containing Protease Inhibitor cocktail. After centrifu-
gation, the cytoplasmic fraction (supernatant) was transferred to a new tube, and the pellet was resuspended in 
extraction buffer III containing protease inhibitor cocktail and benzonase endonuclease. After centrifugation, the 
nuclear fraction (supernatant) was collected. Protein concentrations were determined using BCA Protein Assay 
Kit (Thermo Scientific, Rockland, IL, USA) or DC Protein Assay Kit (Bio-Rad, Hercules, CA, USA). After adding 
5× SDS sample buffer (300 mM Tris-HCI, pH 6.8, 10% SDS, 25% β-mercaptoethanol, 0.05% bromophenol blue, 
50% glycerol), samples were boiled for 5 min, and subjected to SDS-PAGE. Proteins in the gels were transferred 
to a PVDF membrane using a Trans-Blot Turbo Blotting System (Bio-Rad). Following a blocking step with PVDF 
Blocking Reagent for Can Get Signal (TOYOBO, Osaka, Japan), the membrane was incubated with primary anti-
body and probed with the appropriate HRP-conjugated secondary antibodies. The membranes were developed 
using ECL Prime Western Blotting Detection Reagent (GE Healthcare, Little Chalfont, UK), and chemilumines-
cent signals were detected by a LAS-1000 image analyzer (FUJIFILM, Tokyo, Japan). The antibodies used in this 
study were as follows: anti-Vgll2 (described above, 1:1000), Histone H2B (Merck Millipore, 07–371, 1:1000), Sox6 
(Abcam, Cambridge, UK, ab30455, 1:1000), Sp3 (Santa Cruz Biotechnology, Dallas, TX, USA, sc-644, 1:1000), 
Purβ (Bethyl Laboratories, Montgomery, TX, USA, A303-650A, 1:1000), β-Actin (Cell Signaling Technology, 
Danvers, MA, USA, #4970, 1:1000), and anti-rabbit IgG (horseradish peroxidase-linked) and anti-mouse IgG 
(horseradish peroxidase-linked) (Cell Signaling Technology).
High Resolution Gel Electrophoresis. Protein extraction and high resolution gel electrophoresis for 
MyHC isoform separation were performed as described previously64. Briefly, muscle tissues were isolated from 
both legs per mouse was homogenized in buffer (0.1 M Tris-HCl, pH 8.0, 10% SDS, 40 mM DTT, 5 mM EDTA) 
supplemented with protease inhibitor cocktail (Complete Ultra Mini Protease inhibitor cocktail tablets used as 
instructed; Roche) using a BioMasher II homogenizer (Nippi), and 50 ng of protein sample was separated on 
8% acrylamide gel containing glycerol by 140 V for 22 h at 4 °C. The gel was then stained with Silver Stain II Kit 
(Wako) according to the manufacturer’s instructions.
Immunofluorescence. Immunohistochemistry techniques were used for fiber type determination. 
Soleus muscles were harvested and frozen in liquid nitrogen cooled isopentane. Frozen sections (7 μm) were 
cut in a cryostat on microscope slides. Slides were allowed to warm up to room temperature, fixed in 4% 
paraformaldehyde-PBS for 20 min at 4 °C, and permeabilized with 0.1% Triton X-100-PBS for 10 min at 4 °C, and 
immersed in 0.01 M citrate buffer (pH 3.0) at 37 °C for 30 min for antigen retrieval. Slides were then blocked with 
10% normal goat serum (Nichirei, Tokyo, Japan) for 1 h at room temperature, and incubated at 4 °C for overnight 
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with the following primary antibody cocktail: MyHCI antibody (BA-F8), MyHCIIa antibody (SC-71), and 
MyHCIIb antibody (BF-F3) were mixed in equal volume. Slides were then incubated for 1 h at room temperature 
with the following secondary antibody cocktail: Alexa Fluor 488 goat anti-mouse IgG2b (Invitrogen, A-21141, 
1:200), Alexa Fluor 647 goat anti-mouse IgG1 (Invitrogen, A-21240, 1:200), and Alexa Fluor 568 anti-mouse IgM 
(Invitrogen, A-21043, 1:200). Images were captured under the FLUOVIEW FV10i (Olympus, Tokyo, Japan), then 
merged and pseudocolored in FV10-ASW (Olympus). All primary antibodies against MyHC isoforms were pur-
chased from DSMZ (Braunschweig, Germany). Collected cell culture supernatants were used as primary antibody 
solutions.
Co-Immunoprecipitation. Physical interaction between Vgll2 and TEAD1 was analyzed by 
co-immunoprecipi-tation analysis using Dynabeads coupled with anti-rabbit IgG or –mouse IgG according to the 
manufacturer’s instructions (Invitrogen). Prior to Co-IP, we incubated Dynabeads M-280 Sheep anti-Rabbit IgG 
or Dynabeads M-280 Sheep anti-Mouse IgG (Invitrogen) with anti-Vgll2, anti-TEAD1 (BD Biosciences, San Jose, 
CA, USA, 610923), or anti-TEAD4 (abcam, ab58310) antibody (5 μg per 50 μl of beads slurry), respectively, with 
rotation at 4 °C. For Co-IP experiments, muscle tissue was homogenized in buffer (20 mM HEPES-NaOH, pH 
8.0, 150 mM NaCl, 1 mM EDTA, 1.5 mM MgCl2, 0.5% Triton X-100, 10% glycerol) supplemented with Complete 
Ultra Mini Protease inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail using a BioMasher II 
homogenizer. Sonication for 5 cycles of 30 sec ON/30 sec OFF with the Bioruptor UCD-300 (Tosho Electric Ltd., 
Yokohama, Japan) at maximal power setting of homogenates was followed by adding Benzonase Nuclease (Merck 
Millipore) and incubation for 1 h with rotation at 4 °C. Following centrifugation, the supernatant was rotated at 
4 °C for 1 h with antibody-coupled Dynabeads, washed 3 times in PBS (pH7.4), and eluted with 50 μL sample 
buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue) and 
denatured at 95 °C for 5 min. After denaturation, samples were subjected to SDS-PAGE. The negative control was 
performed using lysates with beads (no-Ab) without any antibodies. Transferring and blocking were performed 
as described above. The membranes were then incubated with the primary antibody against Vgll2 (1:1000), 
anti-TEAD1 (1:1000) and anti-TEAD4 (1:1000) overnight at 4 °C diluted in Can Get Signal solution, and probed 
with the appropriate HRP-conjugated secondary antibody. The secondary antibodies used in this study were as 
follows: anti-rabbit IgG, Conformation Specific (Cell Signaling Technology, #3678, 1:10000) and anti-Mouse IgG, 
Light Chain Specific (Jackson ImmunoResearch, West Grove, PA, USA,115-035-174, 1:20000).
Treadmill Exercise. The muscle endurance test was performed as described previously65. In brief, we used a 
MK-680S treadmill (Muromachi Kikai Co., Ltd., Tokyo, Japan). For 3 days, animals were acclimated to treadmill 
running for 5 min at a speed of 10 m/min on a 0% grade. After acclimation, animals ran on a treadmill with a 
10% uphill grade starting at a speed of 10 m/min for 5 min. Every subsequent 2 min, the speed was increased by 
2 m/min until the mice were exhausted. Exhaustion was defined as the inability of the animal to remain on the 
treadmill despite mechanical prodding. Running time and speed were measured, and the distance was calculated.
Grip Strength. Grip strength was measured as described previously65. In brief, we use a MK-380M grip 
strength meter (Muromachi Kikai Co., Ltd.). The grip strength of each individual mouse was measured 10 times, 
the same measurements were repeated on the next day, and the highest value of each experiment was used.
Statistical analyses. Quantitative analyses were performed on at least 3 independent biological samples. 
Data are expressed as the mean ± SEM. Data were analyzed by using the Student’s t-test or one-way ANOVA with 
Dunnett post hoc test. P < 0.05 was considered as significant.
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